Caremark will sell a genetically engineered drug.
- Share via
Within two weeks, the Newport Beach health-care company will begin dispensing its new drug Protropin, a human growth hormone made by Genentech of South San Francisco. The drug is used to treat dwarfism, a condition affecting up to 15,000 children. Under the agreement, Caremark will distribute Protropin nationwide to patients not served by hospital pharmacies; Genentech sells directly to the hospital pharmacies. Last week, Protropin became the second biotechnology drug to receive Food and Drug Administration approval for sale in the United States.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
